ImmuneWorks has received a $300,000 investment from Indiana Seed Fund I to help the Indianapolis company research a manufacturing process for a drug it is developing to fight idiopathic pulmonary ...
FAST BioMedical thought it was on to something big—a new kidney test for hospital patients with a potential market of $1 billion. But last year, FAST stumbled onto an even bigger opportunity—a ...
BioWorld briefs for Nov. 3, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results